SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis

SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis

KDTB Research, a drug development start-up developing a new medicine for treatment of Tuberculosis, closed a successful funding round with the assistance of SORTIS Invest. The financing was led by Innovation Capital – a venture capital fund located in Sofia, Bulgaria. KDTB Research is a company that specializes in developing superior drugs for treatment of […]

>> SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis
The Quality Group Continues its Expansion with the Acquisition of GOT7 Nutrition

The Quality Group Continues its Expansion with the Acquisition of GOT7 Nutrition

The Quality Group (“TQG”) has signed an agreement to acquire GOT7 Nutrition GmbH & Co. (“GOT7”). This is yet another acquisition for “The Quality Group”, which is currently in an active expansion period, and has been looking for strategic growth in the food supplements space through M&A. Carlsquare has been the exclusive advisor of TQG […]

>> The Quality Group Continues its Expansion with the Acquisition of GOT7 Nutrition